IVAN ROSAS to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications IVAN ROSAS has written about Cyclooxygenase 2 Inhibitors.
Connection Strength
0.166
-
Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial. Eur Respir J. 2020 05; 55(5).
Score: 0.166
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.